Furthermore, we also analyzed the TCGA ccRCC dataset, high expression levels of EZH2 and SMURF1 and low expression of DAB2IP predicted poor overall survival of ccRCC patients (Fig. S9B–D). This evidence concerns the gene EZH2 and nonpapillary renal cell carcinoma.